Chemoinformaics analysis of TARAXASTEROL-ACETATE
| Molecular Weight | 468.766 | nRot | 1 |
| Heavy Atom Molecular Weight | 416.35 | nRig | 28 |
| Exact Molecular Weight | 468.397 | nRing | 5 |
| Solubility: LogS | -6.933 | nHRing | 0 |
| Solubility: LogP | 7.433 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 86 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 32 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 89.7172 |
| nHD | 0 | BPOL | 54.7708 |
| QED | 0.284 |
| Synth | 4.855 |
| Natural Product Likeliness | 3.129 |
| NR-PPAR-gamma | 0.036 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.449 |
| Pgp-sub | 0 |
| HIA | 0.009 |
| CACO-2 | -4.944 |
| MDCK | 0.00000912 |
| BBB | 0.604 |
| PPB | 0.99926 |
| VDSS | 1.288 |
| FU | 0.0230444 |
| CYP1A2-inh | 0.024 |
| CYP1A2-sub | 0.35 |
| CYP2c19-inh | 0.054 |
| CYP2c19-sub | 0.964 |
| CYP2c9-inh | 0.072 |
| CYP2c9-sub | 0.279 |
| CYP2d6-inh | 0.051 |
| CYP2d6-sub | 0.756 |
| CYP3a4-inh | 0.188 |
| CYP3a4-sub | 0.654 |
| CL | 6.128 |
| T12 | 0.008 |
| hERG | 0.012 |
| Ames | 0.02 |
| ROA | 0.282 |
| SkinSen | 0.052 |
| Carcinogencity | 0.01 |
| EI | 0.129 |
| Respiratory | 0.663 |
| NR-Aromatase | 0.222 |
| Antiviral | No |
| Prediction | 0.675623 |